CLINICAL_TRIALS
research
· 2013-09-05
Clinical Trial Update: The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy [Phase 1]
Summary
A Phase 1 clinical trial examining whether glucose intolerance contributes to idiopathic axonal polyneuropathy; the study was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Chicago | Conditions: Idiopathic Axonal Polyneuropathy, Abnormal OGTT | Phase 1 | Status: TERMINATED